JerryNickMD

Pulmonology • Denver, CO

Critical Care Medicine, Cystic Fibrosis, Pleural Disease

Professor of Medicine, National Jewish Health and University of Colorado School of Medicine

Join to view full profile

Dr. Nick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nick's full profile

Already have an account?

Office
1400 Jackson St, A548
Denver, CO 80206
Phone+1 303-398-1579

Education & Training

University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1997
University of WashingtonResidency, Internal Medicine, 1989 - 1992
University of Washington School of MedicineClass of 1989

Certifications & Licensure

CO State Medical License 1994 - 2025
OK State Medical License 2020 - 2022
NM State Medical License 2020 - 2021
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Viral-Related Neutrophil Response and Condition Severity in People With ARDS Start of enrollment: 2007 Aug 01
Completed
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies Start of enrollment: 2008 Feb 01
Completed
A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF) Start of enrollment: 2011 May 01
Completed
Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function Start of enrollment: 2012 Sep 01
Completed
Phase 2
Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine Solution Start of enrollment: 2012 Nov 01
Completed
PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis Start of enrollment: 2013 Dec 01
Enrolling by invitation
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF Start of enrollment: 2014 Jan 01
Completed
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis Start of enrollment: 2014 Jan 01
Enrolling by invitation
Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF) Start of enrollment: 2016 Oct 21
Completed
Phase 4
Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection Start of enrollment: 2019 Jun 20
Terminated
Phase 2
Improving P. Aeruginosa Detection With Breath-based Diagnostics (IMPACT-Breath) Start of enrollment: 2019 May 03
Recruiting
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

51 citations
Selective Metabolism of Hypothiocyanous Acid by Mammalian Thioredoxin Reductase Promotes Lung Innate Immunity and Antioxidant Defense
Joshua D. Chandler, David P. Nichols, Jerry A. Nick, Robert J. Hondal, Brian J. Day
The Journal of Biological Chemistry. 2013-06-21
91 citations
A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense.
Michael B. Fessler, Scott K. Young, Samithamby Jeyaseelan, Jonathan G. Lieber, Patrick G. Arndt
American Journal of Respiratory and Critical Care Medicine. 2005-03-15
72 citations
Effects of Liver X Receptor Agonist Treatment on Pulmonary Inflammation and Host Defense
Kathleen A. Smoak, Jennifer H. Madenspacher, Samithamby Jeyaseelan, Belinda Williams, Darlene Dixon
Journal of Immunology. 2008-03-01

Press Mentions

Clarametyx Biosciences Announces Progress on Study of Antibody Therapy CMTX-101 for Infections Associated with Cystic FibrosisOctober 17th, 2024
Bacteria-Killing Viruses Discovered by Researchers Are Saving Patients Who Have No Other OptionsAugust 24th, 2022
Bacteria-Killing Viruses Are Saving Patients Who Have No Other OptionsJune 5th, 2022
Join now to see all